ZIM Laboratories Limited (BOM:541400)

Market Cap	3.40B -19.9%
Revenue (ttm)	3.78B -2.7%
Net Income	69.83M -54.6%
EPS	1.43 -54.4%
Shares Out	53.50M
PE Ratio	44.35
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,958
Average Volume	4,041
Open	65.45
Previous Close	63.62
Day's Range	61.20 - 65.45
52-Week Range	60.00 - 126.95
Beta	0.36
RSI	40.57
Earnings Date	May 22, 2026

About ZIM Laboratories

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and ...

• Industry: Pharmaceutical Preparations
• Founded: 1984
• Employees: 577
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 541400

Financial Performance

In fiscal year 2025, ZIM Laboratories's revenue was 3.79 billion, an increase of 3.16% compared to the previous year's 3.68 billion. Earnings were 121.65 million, a decrease of -29.46%.